Cross-fund · 5 holders
IBRX
IMMUNITYBIO INC
CUSIP 45256X103
5
Tracked holders
$318.7M
Aggregate value
65,863,722
Shares
5
Active funds
Funds holding IBRX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $202.1M | — | +745,224 | +2.9% |
| Vanguard | Institutional | Q4 2025 | $64.9M | — | +5,122,052 | +18.5% |
| Citadel | Multi-Strategy | Q1 2026 | $39.4M | 0.01% | +3,464,104 | +207.2% |
| Millennium | Multi-Strategy | Q1 2026 | $11.1M | — | +1,325,616 | +1119.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.2M | — | +160,100 | NEW |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.